Company: WHWK
Filing Date: 2025-02-18
Form Type: DEFA14A
Source: 0001193125-25-028632
Chunk: 5

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-02-18
Form: DEFA14A
Chunk 5
---
 The offer and sale of securities of Aadi described above are being made in a transaction not involving a public offering and the securities have not been registered under the Securities Act of 1933, as amended, and may not be reoffered or resold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements. Concurrently with the closing of the subscription agreement for the financing, the Company and the investors will enter into a registration rights agreement pursuant to which the Company will file, following the closing of the financing, a registration statement with the SEC registering the resale of the shares of Common Stock and the shares of Common Stock underlying the Pre-FundedWarrants sold in the PIPE financing. Contact: IR@aadibio.com 4